Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Surrey

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Fertility and Sterility|June 23, 2019
Impact of elagolix on work loss due to endometriosis-associated pain: estimates based on the results of two phase III clinical trialsRobin M Pokrzywinski, Ahmed M Soliman, Jun Chen, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|May 6, 2018
An evidence-based approach to assessing surgical versus clinical diagnosis of symptomatic endometriosisHugh S Taylor, G David Adamson, Michael P Diamond, et al.
Reproductive Biomedicine Online|April 2, 2019
A multicentre evaluation of the Elecsys<sup>®</sup> anti-Müllerian hormone immunoassay for prediction of antral follicle countMichael H Jacobs, Laura M Reuter, Valerie L Baker, et al.
The New England Journal of Medicine|May 20, 2017
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH AntagonistHugh S Taylor, Linda C Giudice, Bruce A Lessey, et al.
Obstetrics and Gynecology|June 12, 2018
Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension StudiesEric Surrey, Hugh S Taylor, Linda Giudice, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Fertility and Sterility|June 23, 2019
Impact of elagolix on work loss due to endometriosis-associated pain: estimates based on the results of two phase III clinical trialsRobin M Pokrzywinski, Ahmed M Soliman, Jun Chen, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|May 6, 2018
An evidence-based approach to assessing surgical versus clinical diagnosis of symptomatic endometriosisHugh S Taylor, G David Adamson, Michael P Diamond, et al.
Reproductive Biomedicine Online|April 2, 2019
A multicentre evaluation of the Elecsys<sup>®</sup> anti-Müllerian hormone immunoassay for prediction of antral follicle countMichael H Jacobs, Laura M Reuter, Valerie L Baker, et al.
The New England Journal of Medicine|May 20, 2017
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH AntagonistHugh S Taylor, Linda C Giudice, Bruce A Lessey, et al.
Obstetrics and Gynecology|June 12, 2018
Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension StudiesEric Surrey, Hugh S Taylor, Linda Giudice, et al.
Pageof 2